Researchers Discover New Signaling Pathway Linked to Inflammatory Disease

Scientists at the University of California, San Diego School of Medicine have described for the first time a key inhibitory role for the IL-1 signaling pathway in the human innate immune system, providing novel insights into human inflammatory bowel disease (IBD) and potential new treatments… Read the full story from the UCSD Newsroom

Senior author of the study is Eyal Raz, M.D., Professor of Medicine in the Division of Rheumatology, Allergy & Immunology, pictured above.  First author is José M. González-Navajas, Ph.D. Other Department of Medicine faculty coauthors include Lars Eckmann, M.D., Professor of Medicine in the Division of Gastroenterology.

Read the report in the Journal of Experimental Medicine.